Catherine Rougeot

3.1k total citations · 1 hit paper
41 papers, 2.4k citations indexed

About

Catherine Rougeot is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Catherine Rougeot has authored 41 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cellular and Molecular Neuroscience, 14 papers in Molecular Biology and 11 papers in Physiology. Recurrent topics in Catherine Rougeot's work include Neuropeptides and Animal Physiology (15 papers), Pain Mechanisms and Treatments (6 papers) and Peptidase Inhibition and Analysis (5 papers). Catherine Rougeot is often cited by papers focused on Neuropeptides and Animal Physiology (15 papers), Pain Mechanisms and Treatments (6 papers) and Peptidase Inhibition and Analysis (5 papers). Catherine Rougeot collaborates with scholars based in France, United States and Spain. Catherine Rougeot's co-authors include Michaël Messaoudi, Didier Desor, Hervé Javelot, Jean‐François Bisson, Nicolas Violle, Amine Nejdi, Robert Lalonde, Matthieu Pichelin, Murielle Cazaubiel and François Rougeon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Catherine Rougeot

41 papers receiving 2.3k citations

Hit Papers

Assessment of psychotropic-like properties of a probiotic... 2010 2026 2015 2020 2010 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Rougeot France 19 1.4k 801 583 342 314 41 2.4k
Didier Desor France 22 1.4k 1.0× 798 1.0× 635 1.1× 308 0.9× 320 1.0× 55 2.8k
Michaël Messaoudi France 19 1.3k 0.9× 775 1.0× 602 1.0× 177 0.5× 325 1.0× 24 2.3k
Aurelijus Burokas Lithuania 19 1.4k 1.0× 755 0.9× 657 1.1× 223 0.7× 221 0.7× 44 2.3k
Aitak Farzi Austria 25 1.9k 1.3× 1.1k 1.4× 950 1.6× 396 1.2× 414 1.3× 39 3.4k
Kieran Rea Ireland 23 1.1k 0.8× 584 0.7× 571 1.0× 446 1.3× 179 0.6× 47 2.2k
Kazuhito Rokutan Japan 49 3.7k 2.6× 1.4k 1.7× 526 0.9× 222 0.6× 289 0.9× 165 6.8k
M. Hasan Mohajeri Switzerland 32 1.9k 1.3× 1.3k 1.6× 468 0.8× 294 0.9× 219 0.7× 59 3.9k
M.A. Maselli Italy 9 1.2k 0.8× 686 0.9× 461 0.8× 100 0.3× 413 1.3× 23 2.3k
Kenneth J. O’Riordan United States 29 2.9k 2.0× 1.2k 1.5× 829 1.4× 718 2.1× 263 0.8× 52 4.9k
Laurent Ferrier France 27 1.4k 0.9× 714 0.9× 302 0.5× 157 0.5× 992 3.2× 56 3.5k

Countries citing papers authored by Catherine Rougeot

Since Specialization
Citations

This map shows the geographic impact of Catherine Rougeot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Rougeot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Rougeot more than expected).

Fields of papers citing papers by Catherine Rougeot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Rougeot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Rougeot. The network helps show where Catherine Rougeot may publish in the future.

Co-authorship network of co-authors of Catherine Rougeot

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Rougeot. A scholar is included among the top collaborators of Catherine Rougeot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Rougeot. Catherine Rougeot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boucher, Yves, Evelyne Dufour, Vianney Descroix, et al.. (2016). Opiorphin levels in fluids of burning mouth syndrome patients: a case-control study. Clinical Oral Investigations. 21(7). 2157–2164. 28 indexed citations
2.
Marcelo, Filipa, et al.. (2015). Influence of polar side chains modifications on the dual enkephalinase inhibitory activity and conformation of human opiorphin, a pain perception related peptide. Bioorganic & Medicinal Chemistry Letters. 25(22). 5190–5193. 2 indexed citations
3.
Rougeot, Catherine. (2013). Opiorphin Secretion Pattern in Healthy Volunteers: Gender Difference and Organ Specificity. Biochemistry & Analytical Biochemistry. 2(3). 30 indexed citations
4.
Tóth, Fanni, Géza Tóth, Sándor Benyhe, Catherine Rougeot, & M Wollemann. (2012). Opiorphin highly improves the specific binding and affinity of MERF and MEGY to rat brain opioid receptors. Regulatory Peptides. 178(1-3). 71–75. 13 indexed citations
5.
Seebàch, Dieter, Krystyna Patora‐Komisarska, James Gardiner, et al.. (2011). On the Terminal Homologation of Physiologically Active Peptides as a Means of Increasing Stability in Human Serum – Neurotensin, Opiorphin, B27‐KK10 Epitope, NPY. Chemistry & Biodiversity. 8(5). 711–739. 24 indexed citations
6.
Messaoudi, Michaël, Nicolas Violle, Jean‐François Bisson, et al.. (2011). Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticusR0052 andBifidobacterium longumR0175) in healthy human volunteers. Gut Microbes. 2(4). 256–261. 419 indexed citations
7.
Messaoudi, Michaël, Robert Lalonde, Nicolas Violle, et al.. (2010). Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticusR0052 andBifidobacterium longumR0175) in rats and human subjects. British Journal Of Nutrition. 105(5). 755–764. 1013 indexed citations breakdown →
8.
Rougeot, Catherine & Michaël Messaoudi. (2007). La découverte de l’opiorphine humaine. médecine/sciences. 23(1). 37–40. 8 indexed citations
9.
Wisner, A., Evelyne Dufour, Michaël Messaoudi, et al.. (2006). Human Opiorphin, a natural antinociceptive modulator of opioid-dependent pathways. Proceedings of the National Academy of Sciences. 103(47). 17979–17984. 146 indexed citations
10.
Davies, Kelvin P., Moses Tar, Catherine Rougeot, & Arnold Melman. (2006). Sialorphin (the mature peptide product of Vcsa1 ) relaxes corporal smooth muscle tissue and increases erectile function in the ageing rat. British Journal of Urology. 99(2). 431–435. 42 indexed citations
11.
Chamond, Nathalie, Christophe Grégoire, Nicolas Coatnoan, et al.. (2003). Biochemical Characterization of Proline Racemases from the Human Protozoan Parasite Trypanosoma cruzi and Definition of Putative Protein Signatures. Journal of Biological Chemistry. 278(18). 15484–15494. 55 indexed citations
12.
Reina‐San‐Martin, Bernardo, Wim Degrave, Catherine Rougeot, et al.. (2000). A B-cell mitogen from a pathogenic trypanosome is a eukaryotic proline racemase. Nature Medicine. 6(8). 890–897. 124 indexed citations
13.
Rougeot, Catherine, et al.. (2000). The carboxamide feG(NH2) inhibits endotoxin perturbation of intestinal motility. European Journal of Pharmacology. 409(2). 203–205. 7 indexed citations
14.
Rage, Florence, et al.. (1994). GABA<sub>A</sub> and NMDA Receptor Activation Controls Somatostatin Messenger RNA Expression in Primary Cultures of Hypothalamic Neurons. Neuroendocrinology. 60(5). 470–476. 23 indexed citations
15.
Rage, Florence, Stéphan Jalaguier, Catherine Rougeot, & Lucia Tapia‐Arancibia. (1993). GABA inhibition of somatostatin gene expression in cultured hypothalamic neurones. Neuroreport. 4(3). 320–322. 9 indexed citations
16.
Rougeot, Catherine, et al.. (1993). Chronic stress affects in vivo hypothalamic somatostatin release but not in vitro GH responsiveness to somatostatin in rats. Neuroscience Letters. 159(1-2). 166–170. 10 indexed citations
18.
Stell, William K., M. Chaminade, Kathleen M. Metters, et al.. (1990). Detection of Synenkephalin, the Amino‐Terminal Portion of Proenkephalin, by Antisera Directed Against Its Carboxyl Terminus. Journal of Neurochemistry. 54(2). 434–443. 10 indexed citations
19.
Gerozissis, Kyriaki, et al.. (1990). Leukotriene C4-induced release of LHRH into the hypophyseal portal blood and of LH into the peripheral blood. Life Sciences. 46(25). 1857–1865. 9 indexed citations
20.
Saavedra, J. M., Catherine Rougeot, & F. Dray. (1983). Selective Decrease in Immunoreactive Somatostatin in Rat Intermediate Pituitary Lobe after Stalk Section. Neuroendocrinology. 37(2). 164–165. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026